Patent Assignment
Reel/Frame 039901/0249
Change of Name
Recorded: 2016-09-01
Pages: 20
Assignor
DAINIPPON SUMITOMO PHARMA CO., LTD.
Executed: 2014-06-19
Assignee
SUMITOMO DAINIPPON PHARMA CO., LTD.
6-8 DOSHOMACHI 2-CHOME, CHUO-KU, OSAKA, OSAKA, 541-0045, JAPAN
Covered Properties
(2)
Pharmaceutical Compositions of (+)-1,4-Dihydro-7-[(3S,4S)-3-Methoxy-4-(Methylamino)-1-Pyrolidinyl]-4-Oxo-1-(2-Thiazolyl)-1,8-Naphthyridine-3-Carboxylic Acid
Sns-595 and Methods of Using the Same
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 16, 2006
From: HIGAKI, MASARU; NAKAO, SATOSHI
To: DAINIPPON SUMITOMO PHARMA CO., LTD.; SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 018122/0933 →
Security Agreement
May 7, 2012
From: SUNESIS PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 028169/0528 →
Assignment of Assignor's Interest
Jun 24, 2013
From: HIGAKI, MASARU; NAKAO, SATOSHI
To: DAINIPPON SUMITOMO PHARMA CO., LTD.; SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 030672/0088 →
Release of Security Interest
Apr 1, 2016
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 038330/0382 →
Security Interest
May 10, 2016
From: SUNESIS PHARMACEUTICALS, INC.
To: WESTERN ALLIANCE BANK
Reel/Frame 038655/0493 →
Release of Security Interest
Nov 5, 2020
From: WESTERN ALLIANCE BANK
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 054335/0429 →